Agilon Health (AGL)

EBITDA Growth

111.75%

Quarterly · Period ending:

AGL logo

AGL EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported111.75%
AGL Quarterly EBITDA YoY % (-210.69% → 111.75%)
High-resolution chart · PNG

AGL ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Agilon Health EBITDA Growth — Quarterly
Period endingEBITDA Growth
111.7537%
421.2718%
-85.1592%
7.2466%
-321.4346%
-34.5929%
37.9281%
-685.369%
-187.213%
-26.1785%
-209.2517%
45.4695%
52.1401%
183.2007%
4.6296%
20.1641%
94.355%
167.128%
-368.7757%
-13,633.4879%
-210.6854%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.